In small cell lung cancer, the promotion of tumor development by FGFR1 is mediated by the phospholipase C gamma 1 pathway, and retinoblastoma‐like protein 2 is negatively correlated with the expression of FGFR1.162. The gene discussed is FGFR1; the disease is small cell lung carcinoma.